Dihydroorotate dehydrogenase inhibitors are potent antiviral agents against henipaviruses and arenaviruses

This publication has 58 references indexed in Scilit:

• IMPDH inhibition enhances cytarabine efficacy in SAMHD1 ‐expressing leukaemia cells via guanine nucleotide depletion
  Molecular Oncology, 2026
• Ferroptosis inhibitors: mechanisms of action and therapeutic potential
  Cellular and Molecular Life Sciences, 2025
• A clinical pharmacokinetic drug-drug interaction study between dextromethorphan and emvododstat, a potent anti-SARS-CoV-2 dihydroorotate dehydrogenase inhibitor
  European Journal of Clinical Pharmacology, 2023
• Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19
  Antiviral Research, 2022
• A recombinant Cedar virus based high-throughput screening assay for henipavirus antiviral discovery
  Antiviral Research, 2021
• Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
  Protein & Cell, 2020
• Medicinal chemistry strategies toward host targeting antiviral agents
  Medicinal Research Reviews, 2020
• Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses
  Antiviral Research, 2018
• Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems
  Antiviral Research, 2016
• Metabolism, mechanism of action and sensitivity profile of fluorocyclopentenylcytosine (RX-3117; TV-1360)
  Investigational New Drugs, 2013